| Model of intestinal chylomicron over-production and Ezetimibe treatment: Impact on the retention of cholesterol in arterial vessels. | |
| | |
MedLine Citation:
|
PMID: 20471328 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The metabolic syndrome (MetS) and conditions of insulin resistance are often characterized by an increase in cardiovascular disease (CVD) risk without a concomitant increase in low-density lipoprotein cholesterol (LDL-C), suggesting that other atherogenic pathways maybe involved. Intestinally derived chylomicron remnants (CM-r) are also thought to contribute to atherogenic dyslipidemia during insulin resistance. Recent animal and human studies suggest that insulin resistance leads to an over-production of intestinal chylomicrons (CM), which can contribute to fasting and post-prandial dyslipidemia during these conditions. We and others have contributed new insights into the mucosal absorption, efflux and secretion of cholesterol and triglyceride (TG) in intestinal CM during conditions of insulin resistance. One of the pertinent discoveries has been that the intestine has the capacity to increase the secretion of CM during conditions of hyper-insulinemia (observed in the JCR:LA-cp rat model). Advances to identify cholesterol-transporter targets have highlighted the contribution of the intestine to whole body cholesterol metabolism. Ezetimibe (EZ) is a novel pharmaceutical compound that reduces intestinal cholesterol absorption. We know that Ezetimibe either alone, or in combination with a HMG-CoA reductase inhibitor (such as Simvastatin [SV]) can decrease both plasma LDL-C and CM-r concentrations. However, the combined effects of these compounds (EZ+SV) on post-prandial dyslipidemia and/or impact on arterial deposition of cholesterol during MetS have not been studied. The focus of this review is to highlight studies using an animal model of MetS and CM over-production (the JCR:LA-cp rat), and to summarize the effects of Ezetimibe on intestinal cholesterol flux, CM metabolism and uptake of cholesterol into arterial vessels. |
| | |
Authors:
|
R Mangat; S Warnakula; Y Wang; J C Russell; R Uwiera; D F Vine; S D Proctor |
Related Documents
:
|
823268 - Relationship of topical dose and percutaneous absorption in rhesus monkey and man. 8698548 - Calcium absorption in rats with distal intestinal resection: influence of type of dieta... 9845218 - Failure of psyllium mucilloid to hasten evaluation of sand from the equine large intest... 19060018 - Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis o... 19788708 - Adoption and maintenance of a mediterranean diet in patients with coronary heart diseas... 10438008 - Evaluation of nitrogen and organic matter balance in the feedlot as affected by level a... |
Publication Detail:
|
Type: Journal Article Date: 2010-05-14 |
Journal Detail:
|
Title: Atherosclerosis. Supplements Volume: 11 ISSN: 1878-5050 ISO Abbreviation: Atheroscler Suppl Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100973461 Medline TA: Atheroscler Suppl Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 17-24 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Metabolic and Cardiovascular Diseases Laboratory, Alberta Institute for Human Nutrition and the Alberta Diabetes Institute, C/O 4-10 Agriculture/Forestry Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecularly imprinted poly[bis(2,2'-bithienyl)methane] film with built-in molecular recognition site...
Next Document: XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair.